The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
This event is free to access but registration is required.
There is an increased need to address new therapeutic avenues to treat pneumonia caused by infectious agents that no longer respond to standard of care therapies alone (e.g. antibiotics). This webinar discussed the concept of targeted immunomodulation as a means to treat pneumonia, with focus on Toll-Like Receptor agonists and aerosol delivery.
The audience can gain a better understanding of immunomodulation and targeted therapies for pneumonia.
Expert presentations and a Q&A session.
Following this webinar, participants will be able to:
